As US healthcare costs continue rising steeply – now over $4 trillion representing nearly 20% of GDP – both federal and state policymakers urgently seek ways to contain runaway expenditure growth. This drive manifests through expansion of programs like Medicare Advantage and Medicaid managed care coupled with accelerating passage of game-changing legislation like No Surprises […]
- Credentialing
- Payer Contracting
- Rate Negotiations
- Medical Billing
- Specialties
- Behavioral Health
- DME
- Genetic Testing
- Urgent Care
- Pharmacogenetic (PGx) Testing
- Toxicology
- Substance Abuse
- Allergy Testing
- Speech Therapy
- Skilled Nursing Facilities
- Oncology
- Pathology
- OBGYN
- Biologics and Specialty Drugs
- Telestroke and Teleneurology
- Digital Therapeutics (DTx)
- Remote Patient Monitoring
- Remote Therapeutic Monitoring
- Home Infusion Therapy
- Sleep Study Labs
- Physical Therapy (PT)
- Occupational Therapy
- COVID-19 Testing
- Blog
- Contact